Ion Channel Modulators
- CFTR Inhibitor II [orb180905]
[328541-79-3]
493.1487
C19H15N3O3BR2
O=C(N/N=C/C1=CC(Br)=C(O)C(Br)=C1O)CNC2=CC3=CC=CC=C3C=C2
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg - SEA-0400 [orb180897]
[223104-29-8]
371.377266
C21H19F2NO3
NC1=CC(OCC)=CC=C1OC2=CC=C(OCC3=CC(F)=CC=C3F)C=C2
100 mg, 250 mg, 1000 mg - Milrinone [orb180785]
[78415-72-2]
211.22
C12H9N3O
CC(N1)=C(C2=CC=NC=C2)C=C(C#N)C1=O
100 mg, 250 mg, 1 g - A-803467 [orb180777]
[944261-79-4]
357.7876
C19H16CLNO4
ClC1C([H])=C([H])C(=C([H])C=1[H])C1=C([H])C([H])=C(C(N([H])C2C([H])=C(C([H])=C(C=2[H])OC([H])([H])[H])OC([H])([H])[H])=O)O1
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - PTC124 (Ataluren) [orb180773]
[775304-57-9]
284.24
C15H9FN2O3
C(O)(=O)C1=CC=CC(C2N=C(C3=CC=CC=C3F)ON=2)=C1
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - Ivabradine hydrochloride [orb180755]
[148849-67-6]
505.0461
C27H37CLN2O5
Cl[H].O(C([H])([H])[H])C1=C(C([H])=C2C(=C1[H])[C@@]([H])(C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N1C(C([H])([H])C3=C([H])C(=C(C([H])=C3C([H])([H])C1([H])[H])OC([H])([H])[H])OC([H])([H])[H])=O)C2([H])[H])OC([H])([H])[H]
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - VX-809 (VX809) [orb180745]
[936727-05-8]
452.41
C24H18F2N2O5
C(O)(=O)C1=CC=CC(C2=NC(NC(C(C3C=C4C(=CC=3)OC(F)(F)O4)3CC3)=O)=CC=C2C)=C1
100 mg, 250 mg, 1 g - HC-030031 [orb154740]
[349085-38-7]
355.391
C18H21N5O3
O=C1C2=C(N=C([H])N2C([H])([H])C(N([H])C2C([H])=C([H])C(=C([H])C=2[H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)N(C([H])([H])[H])C(N1C([H])([H])[H])=O
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - Ivacaftor (VX-770) [orb154675]
[873054-44-5]
392.49072
C24H28N2O3
CC(C1=C(O)C=C(NC(C2=CNC3=CC=CC=C3C2=O)=O)C(C(C)(C)C)=C1)(C)C
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - Azelnidipine [orb146294]
[123524-52-7]
582.65
C33H34N4O6
O=C(OC1CN(C(C2=CC=CC=C2)C3=CC=CC=C3)C1)C4=C(N)NC(C)=C(C(OC(C)C)=O)C4C5=CC=CC([N+]([O-])=O)=C5
100 mg, 250 mg, 1 g